Johnson & Johnson, the world’s largest seller of healthcare products, won approval for the first in a new family of diabetes drugs, giving them the edge against rivals developing similar medicines.

GREATER use of aspirin and other low-cost generic medicines would significantly reduce the toll from heart disease and stroke, according to a seven-year global study.

Development of a pill designed to boost sex drive in women has been halted, the German manufacturer said today.